PATH is accelerating the development of pharmaceutical injection technologies aimed at improving access, adherence, and delivery of essential medicines in resource-constrained settings through product innovation.

Long-acting pharmaceuticals often require parenteral delivery, are viscous, have large or non-standard dose volumes, may not be compatible with standard device materials, and are expensive to manufacture. Innovative delivery devices can help address critical diseases such as malaria, tuberculosis, hepatitis B and C, rabies, Ebola, and other neglected tropical diseases, as well as rising noncommunicable diseases such as cancer and diabetes.

With that aim, PATH is identifying suitable packaging and delivery solutions that can reduce costs, improve access, and maximize impact of long-acting pharmaceuticals.